Cargando…

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort

Detalles Bibliográficos
Autores principales:	Nordal, Ellen, Zak, Marek, Berntson, Lillemor, Aalto, Kristiina, Peltoniemi, Suvi, Nielsen, Susan, Herlin, Troels, Lahdenne, Pekka, Straume, Bjørn, Fasth, Anders, Rygg, Marite
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403116/ http://dx.doi.org/10.1186/1546-0096-10-S1-A41

Ejemplares similares

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2017)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
por: Nordal, EB, et al.
Publicado: (2011)

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study
por: Ekelund, Maria, et al.
Publicado: (2017)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
por: Rypdal, Veronika, et al.
Publicado: (2018)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
por: Arnstad, Ellen Dalen, et al.
Publicado: (2021)

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2019)

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
por: Glerup, Mia, et al.
Publicado: (2019)

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, Lillemor, et al.
Publicado: (2014)

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
por: Nordal, EB, et al.
Publicado: (2013)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort
por: Rypdal, Veronika, et al.
Publicado: (2019)

PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, L, et al.
Publicado: (2013)

Non-HLA genepolymorphisms in juvenile chronic arthritis: associations with outcome of disease
por: Alberdi-Saugstrup, Mikel, et al.
Publicado: (2014)

M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
por: Brix, Ninna, et al.
Publicado: (2022)

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
por: Berntson, L, et al.
Publicado: (2008)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

JIA affected sibling pairs present high correlation for ANA and ILAR category
por: Filocamo, G, et al.
Publicado: (2011)

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017)

Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial
por: Tarkiainen, Maarit, et al.
Publicado: (2019)

Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022)

A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis
por: Berntson, Lillemor
Publicado: (2021)

The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man
por: Pelletier, Jean-Pierre, et al.
Publicado: (2002)

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Lahdenne, Pekka, et al.
Publicado: (2018)

The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Flato, Berit, et al.
Publicado: (2018)

A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis
por: Backlund, Malin, et al.
Publicado: (2021)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
por: Öman, Anders, et al.
Publicado: (2021)

Progress made towards enhancement of rheumatology education and practice in Zambia: review of an ILAR-supported project
por: Chipeta, James, et al.
Publicado: (2014)

A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences
por: Hagström, Naima, et al.
Publicado: (2023)

A Pilot Study Investigating Faecal Microbiota After Two Dietary Interventions in Children with Juvenile Idiopathic Arthritis
por: Berntson, Lillemor, et al.
Publicado: (2022)

An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
por: Elfving, Andreas, et al.
Publicado: (2023)

The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Ekelund, Maria, et al.
Publicado: (2018)

Multiple Imputation to Deal with Missing Clinical Data in Rheumatologic Surveys: an Application in the WHO-ILAR COPCORD Study in Iran
por: Mirmohammadkhani, M, et al.
Publicado: (2012)

Incidence of musculoskeletal pain in adult Kuwaitis using the validated Arabic version of the WHO-ILAR COPCORD Core Questionnaire
por: Al-Awadhi, Adel M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_f1kbe0u3uaq2s5gn7s5i1euink